Dr. David E Lederer

Dr. David E Lederer, MD FRCSC

Clinical Associate Eye Health MD

Dr Lederer uses the latest technology and procedures to aid in diagnosing and treating retinal disease.
Affiliate Member McGill University Department of Ophthalmology
Training MD, Tufts University School of Medicine (Boston, MA), 2002
Residency Ophthalmology, McGill University (Montreal, QC), 2007
Fellowship Medical Retina, Duke University (Durham, NC), 2008
Clinical Interests Diagnosis and treatment of macular diseases including Age Related Macular Degeneration, Diabetic Retinopathy and Retinal Vascular Disease

Skills & Experience
David E Lederer, MD is a board certified ophthalmologist who specializes in the treatment of medical diseases of the retina. Specific areas of interest include macular degeneration, diabetic retinopathy, vascular diseases of the eye, infectious and non- infectious intraocular inflammation, inherited genetic disorders of the retina, and systemic medication toxicity of the retinal pigment epithelium.

Dr Lederer began his career at the Tufts University School of Medicine in Boston where he received his MD degree. While studying medicine he was involved with research into the clinical applicability of optical coherence tomography (OCT) and helped to develop clinical protocols that are still in active use today. He also acted as the Administrative Director of a free-care health clinic in downtown Boston. Upon graduation, Dr Lederer completed his residency in ophthalmology at McGill University. There he authored several papers and presentations on medical retinal disease and earned the McGill Department of Ophthalmology Resident Leadership Award. Dr Lederer next went to Duke University in Durham, North Carolina to complete a fellowship in medical retina. Duke University is consistently ranked one of the top 10 eye centers in the United States and afforded Dr Lederer the opportunity to continue his research while taking care of patients. He has published work on the clinical applicability of fundus autofluorescence in macular degeneration, biomarkers of retinal disease, been involved with multiple clinical trials and acted as a peer-reviewer to multiple ophthalmologic journals.

Dr Lederer now continues his career in Montreal where he lives with his wife and family. He is an Affiliate Member at McGill University Department of Ophthalmology, was the first Director of Teleophthalmology for McGill University and is actively involved with medical student, resident, and fellowship education. Dr Lederer also works with Health Canada and the First Nation Communities of Quebec to improve access to ophthalmologic care.

Dr Lederer offers the latest technology to aid in diagnosing retinal disease and provides treatment with all of the current techniques including laser, intraocular injections, periocular injections, photodynamic therapy and immunomodulatory therapy using a variety of medications.

Dr Lederer welcomes consultation requests from ophthalmologists, optometrists and non-eye care professionals.